FUTURE EVENTS

• 27-31 May 2012 - Fourth European Workshop in Drug Synthesis - Certosa di Pontignano/Siena, Tuscany

The workshop (IV EWDSy) organized by the University of Siena will be focused on new Sustainable Process for Medicinal Chemistry. The fourth edition will be taking place from the 27th of May to the 31st of May 2012 in Certosa di Pontignano, just outside the city of Siena (Tuscany). This year the most important aspects are morning lectures of well known researchers, afternoon working sessions and selected short presentations from brilliant young researchers. Just like in the previous years, the first and the last two days consist in lessons in the morning and exercises in the afternoon, while the third day will be composed of lectures in the morning and discussions in the afternoon. Morning and early afternoon sessions will consist of plenary lectures and will be followed by presentations from young researchers and PHD students selected on the basis of the submitted abstracts.

 The programme will include the following seventeen speakers:

For further information please visit www.unisi.it/eventi/ewds/

• 19-20 July - 7th International Workshop on HIV Transmission - Washington, D.C, USA

This workshop brings together researchers, clinicians, and public health officials in order to better understand – and fight – the spread of HIV. Organizers hope the event will provide an opportunity for the sharing of knowledge across disciplines in order to contain the epidemic.

Registration and information.

• 22-27 July - 19th International AIDS Conference, AIDS 2012 - Washington, D.C, USA

This conference brings people working in the HIV field together with policymakers, individuals living with HIV, and anyone else working to end the epidemic. Expected to draw over 20,000 attendees from almost 200 countries, the event encourages dialogue, shared knowledge, and the presentation of new discoveries.

http://www.aids2012.org

• 30 July -1 August, 2012 - 3^rd Annual Symposia of HIV (HIV-2012), Guangzhou, China

The conference will take place within the framework of the 2^nd Annual World Congress of Microbes-2012 (WCM-2012) and it will highlight some recent breakthrough research and development of HIV prevention and treatment by taking on a multilateral aspect of program icluding  AIDS Global Prevention and Cooperation,
Epidemiology, Virology; Immunology in HIV Infection,  Mother-to-Child Transmission and much more.

For further details please visit http://www.bitlifesciences.com/wcm2012/fullprogram_hiv.asp

• 5-8 September 2012 - The 3rd European Conference of Immunology, ECI 2012 - Glasgow, Scotland

This conference is one of the largest gatherings of immunologists in Europe, seeks to share the most recent developments in that field. This event is organized by the British Society for Immunology and is held every three years.

Official website

• 15-17 October 2012 - The 13th congress of the International Union against Sexually Transmitted Infections, IUSTI 2012 - Melbourne, Australia

The congress will bring together STI experts from all over the world in hopes of tackling these diseases. The event allows participants to consider STI issues from a range of perspectives, and features HIV topics as part of its agenda.

http://www.iusti2012.com

• 11-15 November 2012 - Eleventh International Congress on Drug Therapy in HIV Infection - Glasgow, Scotland

The HIV11 conference addresses new developments in HIV treatment while providing a forum for the assessment of new possibilities in the field. The event will also consider the different settings in which new findings are to be applied, allowing participants to identify key prospects and challenges in these areas.

http://www.hiv11.com/

• 16-19 October 2013 - Fourteenth European AIDS Conference - Brussels, Belgium

The 14th European AIDS Conference EACS is organized by the European AIDS Clinical Society (EACS), which is a not-for-profit scientific society of European clinicians and researchers, active in the field of HIV/AIDS and established in 1991. This year the conference will take place from the 16^th to 19^th October 2011 in Brussels, Belgium.

PAST EVENTS

• 23-25 May - ISHEID 2012 International Symposium HIV & Emerging Infectious Diseases, Marseille, France

The ISHEID seeks to promote scientific excellence and to strengthen the global commitment against HIV/AIDS by presenting new scientific knowledge and offering many opportunities for structured dialogue on the major issues facing the global response against HIV/AIDS.

The 2012 programme will focus on current ‘hot topics’ in HIV research: understanding the mechanisms of HIV persistence and maintenance in reservoirs, trying to find a cure, socioeconomic and policy aspects.

Different sessions will tackle ‘Human Rights & HIV/AIDS’, ‘Prevention of HIV Transmission’, ‘Access to Care’.

For further details please visit http://www.isheid.com

• 15-18 April 2012 - The International Microbicides Conference: a global forum to present the latest information on microbicides

The Conference will take place from the 15^th to the 18^th April 2012 in Sidney, Australia and it will aim at sharing the latest development in HIV prevention through microbicides and other technologies. Again, as in the previous editions, Microbicides Conference confirms to be the leading event where cutting edge research will be presented by world experts.

This year in Sidney, the participants will be given the opportunity to interact with networks of scientists and researchers at every level of microbicides development and to share views and experiences in HIV prevention strategies.

There will be a strong emphasis on the role of community in both research and implementation of scientific results and it will be enhanced the interdisciplinary aspect, including basic science, clinical research, public health, prevention science and social research.

For more information, please visit the official website of the Conference

• 19-20 March 2012 - HIV in Europe - Copenhagen, Denmark
  

This event focuses on optimal testing and earlier care of HIV, aiming to inform leaders, policymakers, and the public about the dangers of
delayed treatment. It will also discuss current standards and outline ways these can be improved.

More information on the official website

• 05-08 March 2012 - The 19th Conference on Retroviruses and Opportunistic Infections (CROI) - Seattle USA

The conference brings together researchers and clinicians, giving participants
the opportunity to discuss human retroviruses and their effects. The goal is to translate current research into real progress
in slowing the AIDS epidemic.  Official website of the conference

• 01 Dezember 2011 - World AIDS day – Time to wear the red ribbon

Started in 1988, The World AIDS day strives to increase awareness of the worldwide spread of HIV infection, raise money and fight existing prejudices. As an event that is present all over the world, the day reminds people how everyone around the world is equally affected; it is a threat to all age, gender, race, on every continent.

Each year presents a different theme, highlighting a specific matter concerning the infection; such as ‘Universal Access and Human Rights’ or ‘Stigma and Discrimination’. This year’s theme is yet to be decided. One is for sure; all those who care should wear the red ribbon, the symbol of AIDS awareness, to show their compassion and support for the issue.
 

For more information, please take a look at the official website

• 30 November 2011 - AIDS and Mobility conference held as part of World AIDS day

The conference, which is organized by The International Organization for Migration, will highlight how AIDS remains a serious and wide spread health problem, giving a special focus on how the virus is affecting the migrant population.

The conference hopes to raise awareness and mobilize potential stakeholders, practitioners and policy makers around the issue of HIV and migration.

The event will also serve as a platform for the AIDS and Mobility (A&M) project.

A&M is an European Commission co-founded project, among others coordinated by the Ethno-Medical Centre (EMZ, Hannover) and partnered by IOM, the European AIDS Treatment Group (EATG) and the Italian National Institute for Health, Migration and Poverty (NIHMP, Rome).

• 12-15 October 2011 - 13th European AIDS Conference will be organized by EACS

The 13th European AIDS Conference EACS is organized by the European AIDS Clinical Society (EACS), which is a not-for-profit scientific society of European clinicians and researchers, active in the field of HIV/AIDS and established in 1991. This year the conference will take place from the 12^th to 15^th October 2011 in Belgrade, Serbia.The programme includes scientific plenary lectures as well as abstract-driven sessions presenting latest original research in the field of HIV medicine. It also provides the opportunity to highlight any issues particularly relevant to the HIV epidemic in Serbia, the host city of the conference, and the larger South-eastern European region. One of the important goals of the EACS is to promote an interest in HIV clinical research amongst young researchers and clinicians from across Europe. Therefore, the participation of junior researchers is a good chance to promote their scientific results during the conference and discuss them together with the other experts at different stage in their careers.

If you want to know more about the conference, please take a look at the official website

• 17-21 September 2011 and 24-28 September 2011 - Global Summit on HIV/AIDS and Female Trafficking Conference

The Global Women Health Organization (GWHO) is organizing a Global Summit on HIV/Aids and Female Trafficking that will take place from 17th-21st September to 2011 in Washington, D.C USA and from 24th-28th September 2011 in Senegal.

This case study uses the example of the Trafficking of Women into Europe for reasons of prostitution and sexual exploitation to highlight the human rights violations committed against women, the massive infection of HIV/AIDS among the women, and the social repercussions of the most profitable global trade.

The main topics that will be discussed during the conference are the following: prevention of HIV Transmission, HIV Pharmacology, antiretroviral, searching for a Cure, human right and access to care, primary HIV infection and reservoirs, viral hepatitis and emerging infectious diseases

The Summit will include interactive workshop sessions that will enable participants from different fields of work to share best practice, exchange ideas, empower each other and discuss the latest research findings. The main objectives are to enhance scientific and practice-based research, best practice, to influence key policy makers to increase their commitment to HIV/AIDS care and treatment and undertake actions, and finally to improve public awareness of the impact of and global response to HIV/AIDS & Female Trafficking through enhanced media coverage.

• 4-7 October 2011 - The 4th International Conference on Retroviral Integration in Siena

On the “International Meeting on Retroviral Integration” researchers, basic scientists and clinicians come together to advance our knowledge on the integration of the retroviral DNA into the host chromatin. It blends the fields of chemistry, biology and clinical research in order to translate basic research into the clinic.
The 4th meeting in Siena, Italy, will be held between the 4 and 7th of October, 2011 and will cover all aspects of retroviral integration, spanning from biochemistry and structural biology to drug discovery and the clinics of integrase inhibitors.
A mini symposium will highlight the role of retroviral integration in gene therapy and will bring leading scientists in this field together to discuss advances in gene therapy.

Check the event website for more details

• 17-20 July 2011 - IAS’s Conference on HIV Pathogenesis, Treatment and Prevention

IAS will be hosting its 6th Conference on HIV Pathogenesis, Treatment and Prevention. The event will be held in Rome, Italy from the 17th till the 20th of July, 2011 in partnership with the Italian National Health Service.
The event, held every two years, is the world’s largest open scientific conference on HIV/AIDS and hosts about 5000 international delegates.
The conference is a great opportunity for all participants – leading scientists, clinicians, public health experts and community leaders – to discuss the latest biomedical HIV science. Essentially, the event also serves as a platform for professional development, dialogue and debate.
As one of the major topics of AIDS research today, ‘prevention science’ will be one of the key issues discussed, with a section dedicated to microbicides as an ARV prevention method.

For further information on the event, please visit the official website of the conference.

• 10 July 2011- EATG’s Annual Shareholder Meeting

The European AIDS Treatment Group (EATG) will present its recent findings and work results to its shareholders on the 10th of July. The meeting will also serve as a platform to discuss new ideas for EATG’s upcoming projects.

For more information on EATG and its work, please visit the official website

• 7-10 June 2011 - 5th South African AIDS conference

With the theme “Leadership, Delivery and Accountability”, the 5^th South African AIDS conference wishes to address questions such as: ‘Who gets AIDS prevention?’, ‘How should this prevention be packaged?’, ‘Who pays for it?’ or ‘Why does it work?’

Amongst other issues, important local microbicide studies will be discussed through a wide range of presentations, debates, skill building sessions and special presentations.

To learn more about the event please visit the official website

• May 2011 - Trial of microbicide ring in final phase

Thirty years into the AIDS epidemic, and 10 years since the landmark UN General Assembly Special Session on HIV/AIDS, the world will come together to review progress and chart the future course of the global AIDS response at the 2011 UN General Assembly High Level Meeting on AIDS from 8–10 June 2011 in New York.
The High-Level Meeting is being held at a critical time to move from universal access agenda to the achievement of the Millennium Development Goals by 2015.
More info on the UN meeting.
Rwanda is in the third and final phase of testing a vaginal ring containing antiretrovirals, which, if successful, could provide an important female-controlled method of HIV prevention. Malawi, Rwanda, South Africa and Zimbabwe have all been selected to conduct the final phase of the trial. Phases I and II – conducted in Kenya, Malawi, Rwanda, South Africa – assessed the safety and acceptability of a daily application of a gel containing the ARV, dapivirine. Phase I trials involved small numbers of women, followed by expanded safety trials, Phase I/II, which gathered additional safety data among more participants over longer periods. Once the safety trials are complete, longer-term safety and efficacy trials begin. Phase III trials are conducted among high-risk participants so that researchers can see if there is a difference in infection rates between women who use the active microbicide product versus those who use a placebo. This phase looks specifically at the efficacy and gathers information to proceed with putting the product on the general market.

In Rwanda, the trials are being conducted by a local NGO, Project Ubuzima, with the International Partnership for Microbicides. The project has carried out safety trials for dapivirine gel among more than 60 women and has conducted an HIV incidence study among 1,250 female VCT clients and 800 high-risk women in the capital, Kigali, in preparation for the final phase.

Read more

• May 2011 - Kenya is set to unveil a new medical compound

• May 2011 - Article about research in antiviral drugs published by New Scientist

New Scientist magazine published in the article "Antiviral drugs stop HIV spreading to sexual partners" the results of an international study that has demonstrated that antiretroviral therapy blocks the spread of HIV from an infected person to their uninfected partner.

Full version of the article.

• 22-28 May 2011 - VIII EWDD - Eighth European Workshop in Drug Design in Siena

The University of Siena is pleased to announce the eighth edition of its unique Workshop for researchers from Universities and the Pharmaceutical Industry, to be held in Certosa di Pontignano, Siena, Italy, on May 22nd – 28th 2011.

The Eighth European Workshop in Drug Design will allow maximum 65 participating scientists to work closely with more than 20 leading researchers from both drug industry and academic institutions in exploring solutions to concrete problems encountered in the drug design and discovery process.

Find more details on the event website

• 16-24 May 2011 - The 64th World Health Assembly to review HIV strategy for 2011-2015

Read more

• 10-12 May 2011- eHealth week in Budapest

European healthcare establishments will be faced with substantial challenges over the next decade, such as significant demographic changes and reduced human resources, forcing European leaders to re-design the European Healthcare landscape. eHealth Week 2011 will not only offer an insight into how our leaders are planning and investing for the future, it will also host an exhibition which will showcase leading partners and industry partners, offering innovative solutions for our future.

eHealth Week is a collocation of the European Commission’s High Level Ministerial Conference and the World of Health IT Conference & Exhibition.It was in 2010 hailed as Europe's largest pan-European conference: an all encompassing event focusing on leadership and the continuum of care - healthcare from the home to the hospital. The event will also address other related subjects such as pharma and health 2.0.

Find more details on the programme of the event on Worldofhealthit website

• 07 April 2011 - World Health Day on antimicrobial resistance

The World Health Day 2011 will be marked on 7 April 2011 focusing on antimicrobial resistance, including drug resistance issues related to HIV/AIDS. Antiretroviral treatment has been rapidly scaled up in many developing countries in the past decade without major emergence of HIV drug resistance as initially feared.

 Read more

• Specific microbicides can protect against HIV

AIDS Research and Therapyjournal has published the results of a research focused on the use of lubricants, originally designed for vaginal application. The research has also developed and tested new, rectal specific, formulations.

Prof. Rohan's group, set in the Department of Pharmaceutical Sciences in the School of Pharmacy at the University of Pittsburgh, has formulated four different lubricants, both water and lipid based, and in different formats which are currently being tested in clinical trials.

According to the Professor Rohan, this research represents a first stage in the production of targeted microbicidal products that will provide a basis for the inclusion of different types of antibiotics, antivirals, and other drugs. These new products, if successful, will contribute to stop the spread of HIV.

Full version of the article

• EUROCOORD "European Network of HIV/AIDS Cohort Studies to Coordinate at European and International level Clinical Research on HIV/AIDS"

EUROCOORD is the new pan-european network which will give help to the research centers of HIV. Its mission will be provide information to the specialists regarding questions which need figures at a statistic level.

« European Network of HIV/AIDS Cohort Studies to Coordinate at European and International level Clinical Research on HIV/AIDS » emerges from the experience of other networks like EuroSIDA, CASCADA and PENTA, as well as COHERE (Collaboration of HIV Epidemiologic Research in Europe, which includes projects of scientist research about VIH not financed by the European Union).

This new web will offer figures and statistics of more than 250.000 patients of HIV throughout the European continent, allowing a wide spectrum of results by sex, age, way of transmission, ethnic group or social layer, among others. This information will let to explode the differences between diverse groups and sub-groups of patients, refining the conclusions of the researchers, in pro of a best quality of life of the patients

The net is ready since last January and is included in the 7th Framework Programme of the EU. It contains with partners of 17 countries, inside and outside of the Europe of the 27. The Medical Research Council of London (UK) is the coordinator of EUROCOORD.

The complete details of this project in Cordis

• The AIDS Healthcare Organization will run the Global AIDS Conference

The Global AIDS Conference, organized by the AIDS Healthcare Organization (AHCO), will be held in two countries: the upcoming Global Summit will take place from the 22nd until the 25th of February 2011 in Washington, D.C. (USA), while the second meeting will be celebrated in Saint Louis (Senegal) from the 28th until the 3rd of March.
The summit will deliver interactive workshop sessions that will enable delegates to share best practice, exchange ideas, empower each other and discuss the latest research findings.

If you are interested to participate representing your country, contact the secretariat of the organizing committee: secret_global_submit@globomail.com
For more information contact Ms. Marian Martins: mar_martins@globomail.com

• 28 September 2010 The AIDS VACCINE 2010 Conference

Starting on the 28^th of September in Atlanta- Georgia- until 1^st October, the AIDS VACCINE 2010 will be a further occasion to celebrate a decade of collaboration, education, and the spirited exchange of scientific ideas, all with the purpose of advancing the science of HIV vaccines.

The conference has been organized by the Center for AIDS Research at Emory University and the Global HIV Vaccine Enterprise and it represents now the major venue for investigators, providing a world stage on cutting edge HIV research presented and debated among the international community.

Prof. Robin Weiss, one of the CHAARM partners of the University College London, will attend the conference with Dr. Willie Koh, a researcher working in his laboratories.

During the poster session Dr. Koh will present some findings on the llama VHH, a research which is partially supported by CHAARM project.

For further information, please visit the website

• 20 July 2010 CAPRISA project results released at the XVIII International AIDS Conference

The results of the CAPRISA004 project have been reported on 19th July 2010 by the Centre for the AIDS Programme of Research in South Africa (CAPRISA), during the 1^st day of the International AIDS Conference.

The project conducted relevant studies on an antiretroviral microbicide gelcontaining tenofovir - an antiretroviral drug widely used in the treatment of HIV. The microbicide proved itself 39% effective in reducing a woman’s risk of becoming infected with HIV during sex and 51% effective in preventing genital herpes infections in the women participating in the trial.

A great results that also CHAARM partners are glad to announce, fostering their commitment in the research of effective microbicides.

CAPRISA was established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York.  CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research.

More info about the CAPRISA004 results on Sciencemag.org and in our Press Releases section.

• 16 July 2010  The XVIII International AIDS Conference. Charting the path of research and policies forward:  “Rights here, right now”

The XVIII edition of the International AIDS Conference takes place from Sunday 18 July to 23 July and represents the occasion to gather all the stakeholders involved in the debate on HIV: from researchers to politicians and patients. An estimated number of 25,000 participants, including 2,000 journalists from more than 100 countries, are expected to attend the conference.

The conference theme “Rights here, right now” was chosen by the organizers, with a view to emphasize the central importance of protecting and promoting human rights in dealing with HIV issues. This means that concrete measures need to be put in place to protect both the most vulnerable and those affected by HIV: like for example, the right for dignity and self-determination for key affected populations; equal access to health care; life-saving prevention and treatment programmes; and the right to evidence-based interventions (based on evidence, rather than ideology). 

Prof. Shattock,  from St. George's University of London, one of the CHAARM project partners is in charge of co- chairing the session on the Mechanism of Transmission of HIV and giving a presentation on HIV transmission entitled “Understanding mucosal immunity and HIV transmission: the way to new prevention technologies”.

Find more details on the programme of the event on AIDS2010 website

• 11 May 2010 International Microbicides Conference quickly approaching

In the 6^th edition of the International Microbicides Conference, that will be held in Pittsburgh, Pennsylvania, on May 22-25, 2010, also CHAARM will be a protagonist.

A dedicated presentation will be given by Charles Lacey , from the University of York and one of the 31 partners of the CHAARM , on the 3^rd day of the conference in the session devoted to the forward looking activities of the research on Microbicides. This presentation will give CHAARM project the opportunity to grab the attention of the research community attending the conference

Furthermore, the presence of the project will be assured by the other project partners that have been selected to participate in the conference. All these partners will deliver a number of varied and diversified lectures and poster presentations on biological-chemical Microbicides related issues, presenting some of the results achieved by their research teams.

MICROBICIDES 2010 is an event fully dedicated to future perspective of the HIV prevention, as the conference title stresses “Microbicides: Building Bridges in HIV Prevention”. The debate will be aimed at increasing collaboration between basic, clinical and behavioral scientists, and bridging emerging research with community partners and advocacy groups involved in HIV prevention.

Click here to download the full agenda of the meeting

Click here to download the full list of our partner presentations and lectures